Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;80(3):481-499.
doi: 10.1007/s13105-024-01022-1. Epub 2024 May 1.

Role of microRNA-363 during tumor progression and invasion

Arya Nasimi Shad  1 , Iman Akhlaghipour  1 , Hawraa Ibrahim Alshakarchi  2 , Ehsan Saburi  3 , Meysam Moghbeli  4
Affiliations
Review

Role of microRNA-363 during tumor progression and invasion

Arya Nasimi Shad et al. J Physiol Biochem. 2024 Aug.

Abstract

Recent progresses in diagnostic and therapeutic methods have significantly improved prognosis in cancer patients. However, cancer is still considered as one of the main causes of human deaths in the world. Late diagnosis in advanced tumor stages can reduce the effectiveness of treatment methods and increase mortality rate of cancer patients. Therefore, investigating the molecular mechanisms of tumor progression can help to introduce the early diagnostic markers in these patients. MicroRNA (miRNAs) has an important role in regulation of pathophysiological cellular processes. Due to their high stability in body fluids, they are always used as the non-invasive markers in cancer patients. Since, miR-363 deregulation has been reported in a wide range of cancers, we discussed the role of miR-363 during tumor progression and metastasis. It has been reported that miR-363 has mainly a tumor suppressor function through the regulation of transcription factors, apoptosis, cell cycle, and structural proteins. MiR-363 also affected the tumor progression via regulation of various signaling pathways such as WNT, MAPK, TGF-β, NOTCH, and PI3K/AKT. Therefore, miR-363 can be introduced as a probable therapeutic target as well as a non-invasive diagnostic marker in cancer patients.

Keywords: Cancer; Diagnosis; Non-invasive marker; Prognosis; microRNA-363.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Adan-Gokbulut A, Kartal-Yandim M, Iskender G, Baran Y (2013) Novel agents targeting bioactive sphingolipids for the treatment of cancer. Curr Med Chem 20(1):108–122 - DOI - PubMed
    1. Akhlaghipour I, Fanoodi A, Zangouei AS, Taghehchian N, Khalili-Tanha G, Moghbeli M (2023) MicroRNAs as the critical regulators of Forkhead box protein family in pancreatic, thyroid, and liver cancers. Biochem Genet. https://doi.org/10.1007/s10528-023-10346-4 - DOI - PubMed
    1. Akhlaghipour I, Taghehchian N, Zangouei AS, Maharati A, Mahmoudian RA, Saburi E, Moghbeli M (2023) MicroRNA-377: A therapeutic and diagnostic tumor marker. Int J Biol Macromol 226:1226–1235. https://doi.org/10.1016/j.ijbiomac.2022.11.236 - DOI - PubMed
    1. An J, Wang X, Guo P, Zhong Y, Zhang X, Yu Z (2014) Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway. Toxicol Lett 229(1):265–272. https://doi.org/10.1016/j.toxlet.2014.06.025 - DOI - PubMed
    1. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M (2010) The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 24(21):2420–2429. https://doi.org/10.1101/gad.1954410 - DOI - PubMed - PMC

LinkOut - more resources